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Selective 5-Lipoxygenase Expression in Langerhans
Cells and Impaired Dendritic Cell Migration in
5-LO-Deficient Mice Reveal Leukotriene Action in Skin
Sandra Doepping1, Colin D. Funk2, Andreas J.R. Habenicht1 and Rainer Spanbroek1
5-Lipoxygenase (5-LO) catalyzes the initial steps in the formation of leukotrienes (LTs), which are implicated in
immune reactions. Recently, it was shown that FITC-triggered epidermal Langerhans cell (LC) emigration to
draining lymph nodes (LNs) is impaired in LTC4 export pump (multidrug resistance-associated protein 1)-
deficient mice. Here, we sought genetic evidence for a role of endogenous LTs in dendritic cell function
through the study of 5-LO-deficient mice. Though DC numbers in skin, spleen, and peripheral LNs were similar
in both 5-LO-deficient and wild-type (WT) mice, DC homing from skin to draining LNs induced by FITC was
reduced by 75% in 5-LO-deficient mice. Moreover, in WT mice, all epidermal LCs, dermal langerinþ LCs, and
subsets of dermal macrophages and langerinþ LCs in T-cell areas of skin-draining LNs markedly expressed 5-LO.
However, the enzyme was noticeably absent in all DC subsets of the dermis, thymus, spleen, Peyer’s patches,
mesenteric LNs, and mucosal surfaces of lung and intestine. As all epidermal cells other than LCs lacked 5-LO
and because differentiation and activation of DCs generated from 5-LO-deficient mice in vitro were normal,
these data support a selective role of endogenous LTs in DC homing following skin sensitization.
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INTRODUCTION
5-Lipoxygenase (5-LO) initiates synthesis of leukotrienes (LTs)
which are implicated in innate and adaptive immune
responses (Samuelsson et al., 1987; Funk, 2001). 5-LO is
expressed in most human leukocytes that participate in
inflammation and the enzyme is also present in human
leukocytes that regulate adaptive immunity including den-
dritic cells (DCs) such as epidermal and mucosal Langerhans
cells (LCs) (Spanbroek et al., 1998), lymph node (LN), and
tonsil-interdigitating DCs, and germinal center mantle zone B
cells, whereas T cells in secondary lymphoid organs lack
5-LO (Spanbroek et al., 2000). Moreover, CD34þ progenitors
from human umbilical cord blood acquire constituents of the
5-LO pathway during DC differentiation and activation and
are capable of generating LTs (Spanbroek et al. 2000, 2001).
Despite these extensive data on human leukocytes, much less
is known about 5-LO expression in mice. Though several
mouse leukocytes of myeloid origin that regulate innate
immune responses have been shown to express 5-LO (Chen
et al., 1995; Murakami et al., 1995; Zhao et al., 2004),
nothing is known about its expression in leukocytes that
participate in adaptive immunity such as DCs, T, or B cells.
Indeed, most studies that sought to determine the role of LTs
in adaptive immunity in mice have relied on functional
assays using 5-LO- or LT receptor (LT-R)-deficient mice, but
the LT-forming cells in these experimental settings have not
been identified (Chen et al., 1994; Goulet et al., 1994; Bailie
et al., 1996; Byrum et al., 1999; Goodarzi et al., 2003; Ott
et al., 2003; Tager et al., 2003; Okunishi et al., 2004).
Circumstantial evidence indicated that LTs may determine LC
migration to draining LNs. Mice deficient in the LTC4 export
pump multidrug resistance-associated protein 1 (MRP1)
showed attenuated LC homing that was restored after
intradermal application of LTC4 (Robbiani et al., 2000).
These data raised the intriguing possibility that the MRP1
phenotype was due to the inability of the LCs to pump
cysteinyl LTs from their intracellular sites of synthesis to the
extracellular milieu. However, as MRP1 is not specific for LTs
but exports a variety of intracellular mediators containing
glutathione adducts (Konig et al., 1999), involvement of
molecules other than LTs in the MRP1 LC phenotype could
not be ruled out.
Here, we examined the role of endogenous LTs in mice
addressing several questions: Which DC and macrophage
subsets express 5-LO? Are endogenous LTs regulators of LC
migration? Do in vitro-generated DCs from 5-LO-deficient
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mice show normal growth, differentiation, and activation
potentials, and do they respond to LTs? Our data reveal a
strikingly selective expression of 5-LO in skin LCs and their
emigrated counterparts in draining LNs. Moreover, both LC
and dermal DC homing is markedly impaired in 5-LO-
deficient mice though their DC differentiation and activation
responses are normal. As LCs translocated 5-LO to the
nuclear envelope in response to FITC activation in vivo and
DCs translocated 5-LO to the nuclear membrane in response
to lipopolysaccharide (LPS) in vitro, these data support a
selective role of LC-derived LTs in skin immunity.
RESULTS
5-LO expression in mouse skin
Immunofluorescence analyses of wild-type (WT) epidermis
for 5-LO, CD11c, and major histocompatability complex
class II (MHC-II) showed prominent 5-LO expression in
virtually all epidermal LCs (Figure 1a–d and m–t), whereas
intraepidermal CD3þ T cells or keratinocytes were 5-LO
(Figure 1i–l). The specificity of 5-LO staining was demon-
strated by the absence of 5-LO fluorescence positivity in LCs
of 5-LO-deficient mice (Figure 1e–h). No apparent morpho-
logical alterations or changes in cell density were observed in
LCs of 5-LO-deficient mice (see below). 5-LO in the dermis
was restricted to MHC-IIþ cells (Figure 1m–p) though not all
MHC-IIþ dermal cells expressed 5-LO. As Dupasquier et al.
(2004) had shown that skin macrophages express MHC-II but
not CD11c, we sought to distinguish the enzyme’s expression
in dermal DCs and dermal macrophages. For this purpose,
we used colocalization experiments of 5-LO, CD11c, and
langerin (Figure 1q–t). These analyses revealed 5-LOþ /
langerinþ /CD11cþ triple-positive DCs (Figure 1t). These
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Figure 1. 5-LO expression in mouse skin. (a–d) Epidermis of WT-and (e–h) 5-LO-deficient mice was stained en face for nuclei (a and e; DAPI, blue), 5-LO
(b and f; red), and MHC-II (c and g; green). 5-LO was restricted to MHC-IIþ LCs (d). (i–p) Back skin cross sections of WT mice and (q–t) dermal sheets were
stained for (i and m; DAPI, blue) nuclei, ( j, n, and r; red), 5-LO (k, green), CD3e (o, green) MHC-II, (s, green) CD11c , or (q, blue) langerin. Broken lines indicate
borders between dermis and epidermis. (p) Arrows indicate 5-LOþ /MHC-IIþ cells and arrowheads 5-LO/MHC-IIþ cells. Asterisks indicate (p) MHC-IIþ
or (t) langerinþ /CD11cþ LCs. (t) Crosses indicate dermal 5-LO/langerin/CD11cþ cells. HF, hair follicle. Bar¼ 50 mm.
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results indicated for the epidermis that 5-LO expression was
restricted to LCs and that the dermis harbored two double
5-LOþ /MHC-IIþ cell populations: a 5-LOþ /langerinþ /
CD11cþ /MHC-IIþ quadruple-positive LC population in
transit and CD11c/5-LOþ /MHC-IIþ cells representing
macrophages.
Lung, intestine, and lymphoid organs are devoid of 5-LOþ DCs
To examine whether peripheral tissue DC subsets and/or
macrophages express 5-LO, trachea and small intestine were
analyzed. In contrast to skin, 5-LO positivity was noticeably
absent from CD11cþ cells in the epithelium and the
subepithelial tissue compartments of trachea or intestine
(Figure S1). Yet, several 5-LOþ leukocytes were identified as
either tissue macrophage subsets: 5-LOþ /CD68þ , 5-LOþ /
F4/80þ , or 5-LOþ /MOMA-1þ , and 5-LOþ /CD11c macro-
phages or rare 5-LOþ /Gr-1þ polymorphonuclear granulo-
cytes (Figure S1 and data not shown). Besides peripheral
tissue DCs, several other DC subpopulations are present in
primary and secondary lymphoid organs, that is, thymus,
spleen, Peyer’s patches, and LNs. To identify 5-LO-expressing
DCs, we double-stained these tissues for CD11c and 5-LO.
However, no CD11cþ cells could be observed in thymus,
spleen, Peyer’s patches, or mesenteric LNs (Figure 2a–d; data
not shown). As LCs were strongly 5-LOþ we examined skin-
draining LNs using DC subset marker antisera. To identify LC-
derived DCs in cutaneous LNs, combinations of CD11c,
CD8a, CD205, and langerin antisera were used with 5-LO
antisera (Figure 2e–t). CD11cþ /5-LOþ DCs expressed CD8a
or CD205 and are located in the T-cell areas of the paracortex
of skin-draining LNs but, as mentioned above, none of the
DC subsets of mesenteric LNs expressed 5-LO (Figure 2a–d).
This markedly selective staining pattern and localization
(Inaba et al., 1997; Shortman and Liu 2002) identified LC-
derived DCs as 5-LOþ DC and direct evidence for this
conclusion was obtained by the occurrence of 5-LOþ /
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Figure 2. 5-LO in mesenteric and skin-draining LNs. (a–d) Mesenteric and (e–t) skin-draining LNs were stained for nuclei (a, e, and q; DAPI, blue), 5-LO
(b, f, j, n, and r; red), CD11c (c, g, k, and o; green), and langerin (s, green). (d) CD11cþ DCs of mesenteric LNs lack 5-LO. (h) Single CD11cþ DCs of
skin-draining LNs express 5-LO. (h) Arrows indicate 5-LOþ /CD11cþ skin-draining LN DCs expressing (l) CD205, (p) CD8a, and (t) langerin. Bar¼20 mm.
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langerinþ double-positive LCs in draining LNs (Figure 2 q–t).
These data revealed that no marker-discernable DC subsets in
lymphoid organs other than LCs express 5-LO under steady-
state conditions. However, other 5-LOþ cells were observed
in lymphoid organs. These were rare Gr-1þ polymorpho-
nuclear granulocytes in thymus, spleen, and LNs and frequent
CD68þ capsular region macrophages (Figure S2 and data not
shown). In contrast to peripheral tissue macrophages and
capsular region macrophages, lymphoid tissue macrophages
(CD68þ macrophages of spleen and LNs and MOMA-1þ
metallophilic spleen macrophages) lacked 5-LO
(Figure S2). When taken together, these data showed that
LCs and LC-derived DCs in skin-draining LNs are strongly
5-LOþ , that all other DC subsets lacked 5-LO, and that
distinct peripheral tissue and lymphoid organ macrophage
subsets expressed 5-LO.
5-LO regulates homing of skin DCs to draining LNs following
contact sensitization by FITC
To determine whether the 5-LO pathway affects LC and
lymphoid organ DC densities under steady state conditions,
we first examined LC and DC numbers of WT-and 5-LO-
deficient mice of the epidermis, spleen, and peripheral LNs.
MHC-IIþ LCs of the epidermis (Figure 3a) and FACS analyses
of isolated CD11cþ /MHC-IIþ DCs of peripheral LNs and
spleen (Figure 3b) revealed no substantial differences in
numbers, distribution, and apparent morphologies of LCs and
DCs. These data showed that LC and other DC subset
densities under steady-state conditions are unaffected by
5-LO. To examine whether 5-LO plays a role during LC
activation and skin sensitization, we applied FITC to
abdominal and ear skins of WT-and 5-LO-deficient mice.
Though FITC painting did not apparently affect emigration of
LCs out of the epidermis (Figure 3a) and 5-LO expression in
skin or recruited additional 5-LOþ cells into skin, quantifica-
tion of CD11cþ /FITCþ DCs in draining LNs showed a
marked DC migration defect in 5-LO-deficient mice that
amounted to approximately 75% in five independent experi-
ments (Figure 3c). To distinguish between LCs and dermal
DCs, we examined langerinþ /FITCþ LCs and CD11cþ /
FITCþ cells at 18 hours after FITC painting. We observed that
both FITCþ skin DC populations (langerinþ and langerin)
were present in draining LNs and that the majority of the cells
were dermal langerin DCs at this time point (Figure 3d–k).
These data demonstrated that the 5-LO pathway did not affect
the number of LCs or other DC subsets or their apparent
differentiation but markedly affected both LC and dermal DC
homing to LNs following activation by FITC.
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Figure 3. Numbers of DCs and LC migration in WT-and 5-LO-deficient mice. (a) Epidermis of WT-and 5-LO-deficient mice were stained for MHC-II. Absolute
numbers of MHC-IIþ epidermal ear-skin LCs of untreated mice (white bars) and mice treated for 18 hours with FITC (black bars) were determined by counting 10
randomly selected microscopic fields (230 mm 230mm) of four mice of each group; numbers were calculated as cells per square mm2. (b) Peripheral
LNs and spleen cells of WT-and 5-LO-deficient mice were isolated as described under Materials and Methods, stained for MHC-II and CD11c, and analyzed by
two-color cytometry. DCs were determined as MHC-IIþ /CD11cþ cells. Numbers are normalized to WT DCs set at 1 in each experiment performed in parallel in
WT-and 5-LO-deficient mice. Each data set is derived from five mice. White bars represent WT mice and black bars represent 5-LO-deficient mice. (c) FITC was
applied to the skin of WT-and 5-LO-deficient mice. Cutaneous LN cells were isolated 18 hours after FITC painting and stained for CD11c followed by two-color
cytometry. The relative numbers of migratory DCs were determined by counting CD11cþ - and FITC-bearing cells. To compare results from different
experiments, data were normalized by dividing the number of FITCþ /CD11cþ DCs of each mouse by the average number of FITCþ /CD11cþ DCs in WT
controls in the same experiment. Each data set is derived from five mice. Values were expressed as SEM and statistically significant differences are indicated
with asterisks (*Po0.05; **Po0.01).After applying FITC for 18 hours to the skin of (d–g) WT and (h–k) 5-LO-deficient mice, skin-draining LN specimens were
prepared and stained for (d and h; blue) langerin and (e and i; red) 5-LO. (f and j) FITCþ DCs were identified by green fluorescence. Arrows indicate
(g) langerinþ /FITCþ /5-LOþ DC and (k) langerinþ /FITCþ DC. Bar¼20 mm.
www.jidonline.org 1695
S Doepping et al.
5-Lipoxygenase Expression in Mouse DCs
5-LO expression and cellular localization in in vitro
differentiated DCs and LCs in vivo
Detailed molecular studies of growth properties and differ-
entiation of primary DCs isolated from tissues ex vivo are
difficult to perform. We generated DCs in vitro from bone
marrow progenitors of 5-LO-deficient and WT mice. FACS
analyses confirmed similar growth properties (data not
shown) and 495% CD11cþ DCs after 14 days of culture
in both genotypes. In addition, FACS analyses of CD11þ DCs
regarding the expression of MHC-II, CD8a, CD40, CD80,
CD11b, and CD205 revealed no differences between the two
genotypes (Figure 4a). Moreover, addition of LPS or tumor
necrosis factor-a for 1–2 consecutive days induced cell
maturation as shown by an increase of CD11cþ /MHC-IIþ
and CD11cþ /CD80þ DCs independent of the 5-LO geno-
type (Figure 4; data not shown) though neither LPS nor tumor
necrosis factor-a induced 5-LO as judged by real-time PCR
and immunofluorescent analyses (not shown). However,
similar to LCs in vivo and unlike DC subsets in peripheral
organs in vivo, the majority of in vitro-generated DCs
expressed 5-LO (Figure 5a–d). These results resembled our
earlier studies of human CD34þ hematopoietic progenitor
cell-derived DCs (Spanbroek et al., 2000). We next stimu-
lated in vitro-differentiated DCs with 100 nM LTD4 or 100 nM
LTB4 and determined intracellular free Ca
2þ transients. Both
LTD4 and LTB4 caused an increase in [Ca
2þ ]i indicating
functional active leukotriene B4 receptors (BLT-Rs) and
cysteinyl leukotriene (cysLT)-Rs (Figure S3a). Quantitative
real-time-PCR analyses of LT-Rs in in vitro-generated DCs
and epidermis extracts supported the view that cysLT1-R was
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Figure 4. WT-and 5-LO-deficient DCs generated from bone marrow progenitors in vitro show similar differentiation and activation phenotypes. (a) Bone
marrow cell were maintained in medium supplemented with GM-CSF for 14 days. (b) Maturation was induced by LPS for the final 24 hours. FACS analyses
revealed no significant differences in DC-marker expression either (a) during GM-CSF-induced differentiation or (b) after LPS-induced final maturation.
Histograms represent data of 104 cells. For FACS analyses, histograms were gated on CD11cþ DCs. Broken lines represent isotype controls, open histograms
represent WT and filled histograms 5-LO-deficient DCs.
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the predominant cysLT-R subtype of these DCs (Figure S3b).
When taken together, these data provided evidence against
an indispensable role of LTs in DC growth and differentiation
and indicated that DCs in vitro retain the ability to upregulate
5-LO expression in response to extracellular factors and that
they respond to both LTB4 and LTD4. Subcellular localization
in the cytosol and nucleus of 5-LO have been associated with
the capacity to synthesize LTs in leukocytes of various origins
(Peters-Golden and Brock, 2001). To clarify whether DC
activation and final maturation induced translocation of 5-LO
to the nuclear envelope, we localized 5-LO before and after
activation of in vitro-differentiated DCs with LPS. 5-LO was
evenly present in the nucleus throughout the nucleoplasm
without apparent preference for the nuclear envelope in
unstimulated DCs (Figure 5a–d). Following activation with
LPS for 1 day, marked translocation of 5-LO to the nuclear
envelope had occurred (Figure 5e–h). More importantly,
similar effects were observed in FITC-treated epidermal
LCs. 5-LO localized in both the LC cytosols including the
DCs, dendrites and nucleus in quiescent skin (Figure 5i–l).
However, 18 hours after FITC painting, translocation of
cytosolic 5-LO to the nucleus had occurred as indicated by
strong nuclear labeling and the disappearance of 5-LO
positivity from the LCs dendrites (Figure 5m–p). These data
indicated that FITC activation of LCs or LPS activation of
DCs stimulates LT formation by 5-LO translocation in vitro
and in vivo.
DISCUSSION
Data detailed above can be summarized as follows: 5-LO
expression in mouse DCs is restricted to LCs, subsets of
dermal DCs, and skin-derived DCs of skin-draining LNs;
tissue DC density and phenotypes are regulated indepen-
dently of the 5-LO pathway in vivo under steady-state
conditions; growth properties and DC marker expression of
5-LO-deficient DCs in vitro are comparable with those of WT
mice; LC and dermis DC activation-dependent migration to
skin-draining LNs is impaired in 5-LO-deficient mice; DCs
generated from bone marrow progenitors in vitro express
5-LO and respond to LTB4 and LTD4; and 5-LO translocates
to the nuclear envelope in LCs in vivo activated by FITC and
in in vitro-generated DCs activated by LPS; like DCs tissue
macrophage subsets show a restricted 5-LO expression
pattern. When taken together, these data provide genetic
evidence for a role of LTs in skin DC immunity.
A major findings of this study is the markedly selective
5-LO expression in LCs, their dermal and skin-draining LN
counterparts and distinct tissue macrophage subsets under
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Figure 5. Intracellular localization of 5-LO in differentiated DCs in vitro after LPS and LCs after FITC activation in vivo. (a–h) Bone marrow cells were
maintained in medium supplemented with GM-CSF for 14 days. (e–h) LPS was added for the final 24 hours. Cytospins of (a–h) in vitro differentiated DCs and
(i–p) epidermal sheets were stained with DAPI (nuclei; blue) and antibodies against 5-LO (red) and CD11c (green). Skin was either (i–l) untreated or (m–p) treated
with FITC for 18 hours. Arrows show nuclear localization of 5-LO in (h) LPS-treated DCs in vitro and in (p) FITC-painted epidermal LCs in vivo. Bar¼ 20 mm.
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steady-state conditions when compared to the corresponding
human DC subsets (Spanbroek et al. 1998, 2000, 2001).
Moreover, in contrast to human germinal center mantle zone
B cells and tingible body macrophages, the corresponding
mouse cells lack 5-LO (Spanbroek et al. 2000; data not
shown). Another major result of our study is genetic evidence
that LTs are endogenous regulators of skin DC migration in
mice. They provide strong support for the conclusion of
Robbiani et al. (2000) that the LC migration defect observed
in MRP1-deficient mice may be, at least in part, owing to the
inability of these LCs to export cysLTs; moreover, we observe
here that mouse lung DCs lack 5-LO and, interestingly, lung
DC migration was recently reported to be normal in MRP1-
deficient mice (Jakubzick et al., 2006). The mechanisms
underlying the striking skin DC migration defect could
conceivably be located in the skin dermal cords and involve
several mechanisms: The finding that FITCþ DCs in draining
LNs is not restricted to langerinþ LCs but also observed in
5-LO dermal DCs – within the time window examined here
– is consistent with both an autocrine action of LTC4 on LCs
and a paracrine action of LTC4 on dermal DCs. The latter
mechanism would involve LC-derived or dermal macro-
phage-derived LTC4 before/during the skin DCs enter
lymphatic vessels. However, the precise mechanisms of LT
effects and their corresponding downstream events could
conceivably involve prostaglandins as 5-LO deficiency has
been associated with overproduction of prostaglandins
(Funk, 2001), because PGD2 has been shown to inhibit DC
migration (Hammad et al., 2003), and PGE2 was demons-
trated to promote DC migration through EP4 (Kabashima
et al., 2003). Our data also indicate the need to reinvestigate
the role of the 5-LO pathway in contact sensitivity. Thus,
Goulet et al. (1994) and Byrum et al. (1999) had failed to
observe effects of 5-LO in contact sensitivity but noted that
the FITC painting system may provide a (too) large excess of
antigen to skin and that probably lower concentrations of
FITC would uncover a role of LTs in contact sensitivity.
Though skin DC 5-LO expression was markedly restricted
to LCs under steady-state and FITC-painting conditions, our in
vitro data are consistent with the possibility that DC 5-LO
may be subject to upregulation in different tissue environ-
ments: 5-LO is strongly expressed in in vitro-generated DCs
raising the possibility that 5-LO may be subject to upregula-
tion in DCs other than LCs under conditions of inflammation
and/or ongoing immune responses in vivo. Thus, it may be of
interest to examine the inducibility of the mouse 5-LO
pathway after triggering DC-activating immune responses,
infection, or inducing other types of inflammatory tissue
reactions in which DCs participate.
Our in vivo and in vitro data do not support a major role of
the 5-LO pathway in DC growth and differentiation. Indeed,
the similar growth properties and phenotypes of WT- and
5-LO-deficient DCs in vitro are consistent with the conclu-
sion of van de Ven et al. (2006) that the defective DC
differentiation pathway that they had observed following
inhibition of MRP1 could not be reversed by LTs (van de Ven
et al. 2006). When we analyzed MHC-II or CD80 in FITCþ
migrated DCs in draining LNs of WT and 5-LO-deficient
mice, no significant alterations were observed. In addition,
the densities and apparent morphologies of DCs in vivo
appeared to be independent of 5-LO. When taken together,
all these data indicate that the 5-LO pathway does not affect
DC growth or DC maturation.
Cytosolic to nuclear envelope translocation of 5-LO in
various unstimulated and activated human and mouse
leukocytes has been associated with inactive or activated
5-LO and/or LT synthesis, respectively (Peters-Golden and
Brock, 2001). That FITC activation of skin DCs in vivo or LPS
activation of DCs in vitro led to a marked translocation of
5-LO to the nuclear envelope indicates ongoing LT synthesis
under conditions of skin hypersensitivity reactions in vivo and
DC activation in vitro. Whether DC-derived or macrophage-
derived LTs act in autocrine and/or paracrine ways and which
LTRs are involved in these actions remain important
questions for future studies. The similar phenotypes of
MRP1- and 5-LO-deficient mice regarding LC migration
would favour selective cysLT action and the cysLT1-R in
regulating LC migration.
MATERIALS AND METHODS
Mice
5-LO-deficient mice on the C57BL/6 background were a generous
gift of Beverly Koller (Goulet et al., 1994). WT mice were purchased
from the Jackson Laboratory (Bar Habor, ME). Mice were housed in
specific pathogen-free animal barrier facilities and used between
8 and 16 weeks. All experiments were approved by the Animal
Ethics Committee of the Friedrich-Schiller-University of Jena, Jena,
Germany.
DC preparations from lymphoid organs
Spleen and peripheral (pooled axillary, brachial, and inguinal) LNs
were collected and single-cell suspensions were prepared by
digestion of teased spleen and LN fragments at 371C for 30 minutes
in RPMI 1640 supplemented with 10% heat inactivated fetal calf
serum (FCS) and 1 mg/ml collagenase type D (Roche, Mannheim,
Germany) followed by gentle pressing through a 30 mm cell strainer
(Miltenyi Biotech GmbH, Bergisch Gladbach, Germany). Spleen
cells were resuspended for 3 minutes at room temperature in
ammonium chloride to lyse residual erythrocytes. Finally, cells were
washed and resuspended in phosphate-buffered saline supplemen-
ted with 2% FCS.
Flow cytometry
For FACS analyses, cells were treated with Fc-receptor blocking
antibodies CD16/32 (clone 2.4G2; BD Biosciences, Heidelberg,
Germany) for 15 min in phosphate-buffered saline supplemented
with 2% FCS and 0.02% sodium azide (wash buffer). After blocking
unspecific binding sites, cells were incubated with appropriate
antibodies for 30 minutes followed by two washes in wash buffer.
For FACS analyses with unlabeled primary antibodies, cells were
treated with phycoerythrin- or FITC-coupled secondary antibodies
for 30 minutes. FACS analyses were performed on a FACSCalibur
instrument and results were analyzed with CellQuest software (BD
Biosciences). The following antibodies were used for phenotypic
analyses: CD8a (clone 53-6.7), CD11b-FITC (clone M1/70), CD11c-
PE (clone HL3), CD40 (clone 3/23), and CD80-PE (clone 16-10A1)
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were obtained from BD Biosciences. Antibody against I-A/I-E-FITC
(MHC-II, clone M5/114.15.2) was obtained from Miltenyi Biotech
GmbH (Bergisch Gladbach, Germany) and antibody against CD205
(clone NLDC-145) was obtained from Serotec (Du¨sseldorf, Ger-
many). Goat anti-rat IgG-FITC (Dianova, Hamburg, Germany) was
used as secondary antibody and rat IgG2a-PE, rat IgG2b-PE, rat
IgG2a-FITC (clone R35-95), rat IgG2b-FITC (clone A95-1; BD
Biosciences, Heidelberg, Germany), and hamster IgG-PE (Serotec,
Du¨sseldorf, Germany) were used as isotype controls.
Confocal laser scan microscopy
For immunofluorescence analyses, ears were separated with forceps
into dorsal and ventral halves. To separate epidermis from dermis,
dorsal halves were incubated for 45 minutes at 371C in phosphate-
buffered saline supplemented with 2% FCS and 20 mM EDTA.
Epidermal and dermal sheets and tissue cross sections (8mm) were
placed on glass slides and fixed with acetone for 10 minutes at 41C.
After rehydration in phosphate-buffered saline supplemented with
2% FCS for 20 minutes at room temperature, specimens were
incubated with rabbit anti-mouse 5-LO antiserum as described (Zhao
et al. 2004) and for double or triple immunofluorescence analyses
with unlabeled primary antibodies against B220 (clone RA3-6B2),
CD3e (clone 17A2), CD8a (clone 53-6.7), CD11c (clone HL3), GR-1
(clone RB6-8C5), and I-A/I-E (clone 2G9) (Becton Dickinson,
Heidelber, Germany) and antibodies against CD68 (clone FA11),
CD205 (clone NLDC-145), F4/80 (clone CI:A3-1), and mouse
metallophilic macrophages (clone MOMA-1) (Serotec, Du¨sseldorf,
Germany) and langerin (clone RMUL.2; eBioscience, San Diego,
CA). Specimens were incubated for 45 minutes with secondary
antibodies, that is, donkey anti-rat IgG-Cy5, goat anti-rat-Cy2, goat
anti-hamster IgG-Cy5, and donkey anti-rabbit IgG-Cy3 (Dianova,
Hamburg, Germany). Sheets were mounted on coverslips with
Permafluor (Beckman, Munich, Germany) and viewed on a Zeiss
Axiovert 200M microscope equipped with a confocal laser scanning
head (LSM510). Pictures were taken and analyzed using LSM510
Image Examiner software (Zeiss, Jena, Germany).
Quantification of LC numbers in epidermal sheets
The density of LC in dorsal epidermal sheets from ear skin was
determined either from untreated mice or 18 hours after FITC
treatment using an objective lens of original magnification  40.
Areas to be counted were selected for even staining and regular
distribution of CD11cþ /MHC-IIþ cells. Ten microscopic fields were
randomly chosen for each individual experiment and four mice per
group were used. Fields containing hair follicles were excluded from
analyses. LCs were counted and medians and SEM were calculated.
FITC-induced in vivo migration of LCs
FITC treatment was performed as described earlier (Robbiani et al.,
2000). Briefly, mice were anesthetized and painted on dorsal sides of
the ears and on shaved areas of neck and back with 25 ml of FITC
(Isomer I, 8 mg/ml; Sigma-Aldrich, Deisenhofen, Germany) dissolved
in dibutylphthalate (Sigma-Aldrich):acetone (1:1). After 18 hours
FITC treatment mice were killed and skin-draining LN were
collected. LN cell suspensions were immunolabeled with anti-
CD11c-PE (BD-Pharmingen, San Diego, CA) and analyzed by two-
color flow cytometry. To compare results from different experiments
and mice, data were normalized by dividing the number of FITCþ /
CD11cþ DCs from each individual by the average number of
FITCþ /CD11cþ DCs in WT controls in the same experiment.
Generation of DCs from bone marrow progenitors
Bone marrow-derived cells were cultured in RPMI-1640 (Invitrogen,
Leek, Netherlands), supplemented with 10% FCS (Bio Whittaker,
Verviers, Belgium), 2 mM L-glutamine (Invitrogen), 50 mM 2-mercap-
toethanol (Sigma-Aldrich), 10 mM N-2-hydroxyethylpiperazine-N 0-
2-ethanesulfonic acid, 1 mM sodium pyruvate, and 100 mg/ml peni-
cillin/streptomycin (Invitrogen), referred to as complete medium.
DCs were generated from bone marrow progenitors as described
(Lutz et al., 1999). Briefly, single-cell suspensions prepared from
bone marrow were cultured in complete medium supplemented
with GM-CSF (10 ng/ml R & D Systems, Wiesbaden-Nordenstadt,
Germany). After 3 days, medium and nonadherent cells were
removed and fresh complete medium with GM-CSF (10 ng/ml) was
added. At day 13, nonadherent cells were considered to be
immature DCs. For final maturation, DCs were cultured for the last
24 hours with LPS (100 ng/ml; Sigma-Aldrich). DC phenotypes were
confirmed by CD8a, CD11b, CD11c, CD40, CD80, CD205, and
MHC-II FACS analyses.
Quantitative real-time-PCR
Total RNA from isolated epidermis or from in vitro-generated DCs
was extracted using the RNeasy kit (Qiagen, Hilden, Germany).
Quantitative real-time-PCR was performed as reported (Spanbroek
et al., 2003) using PCR primers: glyceraldehyde-3-phosphate
dehydrogenase sense-50-GGGAAGCCCATCACCATCTTC-30 and
antisense-50-GTTCTGGGCAGCCCCACGGCC-30, 405 bp, annealing
temperature 711C; CysLT1R sense-50-CAGGAGCCCTGTGAATGG
AG-30 and antisense-50-GTGGCCACTGTTCTTATGTTG-30, 207 bp,
annealing temperature 631C; CysLT2R sense-50-CTGAGTGTGG
TGCGTTTCCTG-30 and antisense-50-GTAGCAGATGGTGAGCGT
GAG-30, 270 bp, annealing temperature 631C.
Determination of intracellular free Ca2þ [Ca2þ ]i
Cells were loaded with fura-2 acetoxymethyl ester (4mmol/l;
Calbiochem, Bad Soden, Germany) for 30 minutes at 371C in
complete culture medium. After rinsing with calcium-buffer
(145 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.5 mM CaCl2, 10 mM N-2-
hydroxyethylpiperazine-N 0-2-ethanesulfonic acid, 10 nM glucose,
and 0.25% bovine serum albumin; pH adjusted to 7.4 using NaOH)
the effects of LTB4 and LTD4 (100 nM; Cayman Chemicals, Ann Arbor,
MI) on [Ca2þ ]i were determined using a fluorescence spectrometer
LS50B and FL WinLab software (Perkin Elmer Applied Biosystems,
Weiterstadt, Germany). Changes in [Ca2þ ]i were expressed as
excitation ratios of 340/380 nm at 510 nm and calculated after
background subtraction as described (Lotzer et al., 2003).
Statistical analysis
For statistical analyses Student’s two-tailed paired t-tests were used.
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